News

MyChesCo on MSN17h
FDA Approves GSK’s Nucala for COPD Patients with Eosinophilic Phenotype
The U.S. Food and Drug Administration (FDA) has approved GSK’s Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with chronic obstructive pulmonary disease (COPD) with ...
Medscape2d
Newly Approved Mepolizumab Mitigates COPD Exacerbations
Mepolizumab, a humanized monoclonal antibody that targets interleukin-5 (IL-5), significantly reduced COPD exacerbations in ...
Health and Me on MSN5d
FDA Greenlights Nucala as New Treatment for COPD
FDA approves Nucala as add-on therapy for COPD with high eosinophils, offering new hope by reducing flare-ups in patients ...
Wyoming Tribune Eagle5d
FDA Approves Nucala for Chronic Obstructive Pulmonary Disease
The U.S. Food and Drug Administration has approved Nucala (mepolizumab) as an add-on maintenance treatment for adult patients ...
MedPage Today5d
FDA Approves Mepolizumab for COPD
Mepolizumab has had a bumpy road to arriving at its indication in COPD. An FDA advisory committee in 2018 declined to ...
COPD News Today5d
FDA approves Nucala as add-on therapy for certain COPD patients
The FDA has approved Nucala (mepolizumab) as an add-on maintenance treatment for certain COPD patients whose disease isn't ...
Contract Pharma5d
FDA Greenlights GSK’s Nucala for Eosinophilic COPD
The FDA has granted approval to GSK's Nucala as an add-on maintenance treatment for adult patients suffering from inadequately controlled COPD.
BioSpace5d
GSK Wins COPD Expansion for Nucala After FDA Delay
The approval tees GSK up to challenge Sanofi and Regeneron, which in September 2024 won the first biologic approval for COPD ...
Managed Healthcare Executive6d
FDA Approves Nucala as Maintenance Therapy for COPD
Nucula’s new indication is as an add-on therapy for patients with COPD who also have an elevated blood eosinophil count.
Monthly Prescribing Reference1mon
Adverse Outcomes Increased With Long-Term Inhaled Corticosteroids in COPD
Significantly greater composite adverse outcome rates seen for long- vs short-term inhaled corticosteroid use for prevalent, inception cohorts. HealthDay News — For patients with chronic ...
Medical News Today2mon
Are COPD inhalers covered by Medicare?
Various types of inhalers, including short- and long-lasting options, are available for managing chronic obstructive pulmonary disease (COPD). A person can get a COPD inhaler through Medicare Part ...